Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis
- PMID: 1568573
- DOI: 10.1016/0016-5085(92)91723-h
Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis
Abstract
Three hundred seven cases (244 gastric, 63 intestinal) of primary gastrointestinal non-Hodgkin's lymphoma (NHL) in stages EI and EII, according to a modified Ann Arbor system, were examined retrospectively. The histological classification for mucosa-associated lymphoid tissue-derived lymphomas was applied. Gastric NHLs (male-female ratio, 0.97; mean age, 64.5 years) were stage EI in 51% and stage EII in 49% of cases. Histological grade of malignancy was low in 41% and high in 59% of cases; all NHLs were B-cell type. Tumors were radically resected in 87%, and overall 2-, 5-, and 10-year survival rates were 61%, 55%, and 46%, respectively. Early lymphomas (substage EI1) had best prognosis (5- and 10-year survival rates, 90% and 70%, respectively). Intestinal NHLs (male-female ratio, 1.1; mean age, 54.4 years) were stage EI in 30% and stage EII in 70% of cases. Histology was low grade in 21% and high grade in 79%, and all but 11 cases were B-cell type. In 58% of cases, radical tumor resection resulted in overall 2- and 5-year survival rates of 44% and 24%, respectively. Major prognosticators for survival in gastric location were low-grade histology, low depth of infiltration, and low stage and radical resectability of lymphoma; all factors were strictly intercorrelated. In intestinal site, radical tumor resectability was highly significant for survival. Cumulative proportion of relapses after 5 years was higher in intestinal than in gastric sites (44% vs. 22%). In conclusion, primary gastrointestinal tract NHLs may represent an entity with respect to characteristic histological features, focal tumor growth, and potential cure by radical resection. Because of late relapses, clinical follow-up is needed.
Similar articles
-
Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.J Clin Oncol. 1994 Aug;12(8):1673-84. doi: 10.1200/JCO.1994.12.8.1673. J Clin Oncol. 1994. PMID: 8040680
-
Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathologic study of 150 cases.Cancer. 1985 Mar 1;55(5):1060-73. doi: 10.1002/1097-0142(19850301)55:5<1060::aid-cncr2820550523>3.0.co;2-8. Cancer. 1985. PMID: 3881161
-
TNM staging system may be superior to Lugano and Ann Arbor systems in predicting the overall survival of patients with primary gastrointestinal lymphoma.J BUON. 2015 May-Jun;20(3):812-9. J BUON. 2015. PMID: 26214635
-
Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.Haematologica. 1997 May-Jun;82(3):305-8. Haematologica. 1997. PMID: 9234576 Review.
-
Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature.Cancer. 1989 Sep 15;64(6):1208-17. doi: 10.1002/1097-0142(19890915)64:6<1208::aid-cncr2820640608>3.0.co;2-z. Cancer. 1989. PMID: 2670184 Review.
Cited by
-
Paris staging system for primary gastrointestinal lymphomas.Gut. 2003 Jun;52(6):912-3. doi: 10.1136/gut.52.6.912. Gut. 2003. PMID: 12740354 Free PMC article. No abstract available.
-
Perforation of bowel lymphoma: beware of atypical presentations.J Gastrointest Cancer. 2014 Jun;45(2):121-5. doi: 10.1007/s12029-014-9582-2. J Gastrointest Cancer. 2014. PMID: 24488497 Review.
-
Refractory peptic ulceration following radiation therapy in primary gastric lymphoma: A report of two cases.Oncol Lett. 2015 Jan;9(1):63-66. doi: 10.3892/ol.2014.2657. Epub 2014 Nov 3. Oncol Lett. 2015. PMID: 25435934 Free PMC article.
-
Marginal Zone B-cell Lymphoma (MALT Lymphoma).Curr Treat Options Gastroenterol. 2004 Apr;7(2):133-138. doi: 10.1007/s11938-004-0034-0. Curr Treat Options Gastroenterol. 2004. PMID: 15010027
-
Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial.J Gastroenterol. 2019 May;54(5):388-395. doi: 10.1007/s00535-018-1517-4. Epub 2018 Oct 16. J Gastroenterol. 2019. PMID: 30327875 Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical